Publications
Detailed Information
Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Ha, Hyerim | - |
dc.contributor.author | Ko, Yeh-Hee | - |
dc.contributor.author | Kim, Kwangsoo | - |
dc.contributor.author | Hong, Junshik | - |
dc.contributor.author | Lee, Gyeong-Won | - |
dc.contributor.author | Jeong, Seong Hyun | - |
dc.contributor.author | Bang, Soo-Mee | - |
dc.contributor.author | Yoon, Sung-Soo | - |
dc.date.accessioned | 2023-07-05T00:34:58Z | - |
dc.date.available | 2023-07-05T09:35:58Z | - |
dc.date.issued | 2023-06-05 | - |
dc.identifier.citation | Thrombosis Journal,Vol.21:63 | ko_KR |
dc.identifier.issn | 1477-9560 | - |
dc.identifier.uri | https://hdl.handle.net/10371/194691 | - |
dc.description.abstract | Background
The Khorana score (KS) has not been well studied in East Asian cancer patients, who have different genetic backgrounds for inherited thrombophilia, body metabolism, and cancer epidemiology. Methods By using the Common Data Model, we retrospectively collected deidentified data from 11,714 consecutive newly diagnosed cancer patients who underwent first-line chemotherapy from December 2015 to December 2021 at a single institution in Korea, and we applied the KS for cancer-associated thrombosis (CAT) prediction. Age at diagnosis, sex, and use of highly thrombogenic chemotherapeutics were additionally investigated as potential risk factors for CAT development. Results By 6 months after chemotherapy initiation, 207 patients (1.77%) experienced CAT. Only 0.4% had a body mass index (BMI) ≥ 35 kg/m2 and changing the cutoff to 25 kg/m2 improved the prediction of CAT. Age ≥ 65 years and the use of highly thrombogenic chemotherapeutics were independently associated with CAT development. KS values of 1 ~ 2 and ≥ 3 accounted for 52.3% and 7.6% of all patients, respectively, and the incidence of CAT in these groups was 2.16% and 4.16%, respectively, suggesting a lower incidence of CAT in the study population than in Westerners. The KS component regarding the site of cancer showed a good association with CAT development but needed some improvement. Conclusion The KS was partially validated to predict CAT in Korean cancer patients undergoing modern chemotherapy. Modifying the BMI cutoff, adding other risk variables, and refining the use of cancer-site data for CAT risk prediction may improve the performance of the KS for CAT prediction in East Asian patients. | ko_KR |
dc.description.sponsorship | This work was supported by the Technology Innovation Program (or Industrial Strategic Technology Development Program) (20004927, Upgrade of CDM based Distributed Biohealth Data Platform and Development of Verification Technology), funded by the Ministry of Trade, Industry & Energy (MOTIE, Korea). The funder was not involved in any stage of the current study, including the design, data gathering, data analysis and interpretation, and decision to submit this work for publication. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | BMC | ko_KR |
dc.subject | Khorana score | - |
dc.subject | Cancer-associated thrombosis | - |
dc.subject | Venous thrombosis | - |
dc.subject | Asian | - |
dc.title | Application of the Khorana score for cancer-associated thrombosis prediction in patients of East Asian ethnicity undergoing ambulatory chemotherapy | ko_KR |
dc.type | Article | ko_KR |
dc.identifier.doi | 10.1186/s12959-023-00505-3 | ko_KR |
dc.citation.journaltitle | Thrombosis Journal | ko_KR |
dc.language.rfc3066 | en | - |
dc.rights.holder | The Author(s) | - |
dc.date.updated | 2023-06-11T03:13:42Z | - |
dc.citation.number | 63 | ko_KR |
dc.citation.volume | 21 | ko_KR |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.